Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2018 | 1 |
2021 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Immunotherapy in rare ovarian cancer.
Curr Opin Oncol. 2021 Sep 1;33(5):447-456. doi: 10.1097/CCO.0000000000000759.
Curr Opin Oncol. 2021.
PMID: 34230441
Review.
PARP inhibitor predictive value of the Leuven HRD test compared with Myriad MyChoice CDx PLUS HRD on 468 ovarian cancer patients from the PAOLA-1/ENGOT-ov25 trial.
Loverix L, Vergote I, Busschaert P, Vanderstichele A, Venken T, Boeckx B, Harter P, Brems H, Van Nieuwenhuysen E, Pignata S, Baert T, Gonzalez-Martin A, Han S, Marth C, Neven P, Colombo N, Berteloot P, Mäenpää J, Olbrecht S, Laga T, Sablon E, Ray-Coquard I, Pujade-Lauraine E, Lambrechts D, Van Gorp T.
Loverix L, et al. Among authors: laga t.
Eur J Cancer. 2023 Jul;188:131-139. doi: 10.1016/j.ejca.2023.04.020. Epub 2023 Apr 27.
Eur J Cancer. 2023.
PMID: 37245441
Item in Clipboard
Positive DESKTOP and Tian Scores Systems Are Adequate to Predict Optimal (R0) Secondary Debulking Surgery in Ovarian Cancer, But a Negative Score Does Not Preclude Secondary Surgery.
Laga T, Lambrechts S, Laenen A, Van Nieuwenhuysen E, Han SN, Vergote I.
Laga T, et al.
Int J Gynecol Cancer. 2018 May;28(4):721-728. doi: 10.1097/IGC.0000000000001219.
Int J Gynecol Cancer. 2018.
PMID: 29561300
Item in Clipboard
Cite
Cite